2018 Liver Cirrhosis Drug Development - Pipeline Analysis Report - ResearchAndMarkets.com

DUBLIN--()--The "2018 Liver Cirrhosis Drug Development- Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.

Over 20 companies and universities are focusing on developing treatment options for Liver Cirrhosis.

This report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Liver Cirrhosis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Liver Cirrhosis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Companies Mentioned

  • Bristol-Myers Squibb
  • BIOCND Inc
  • Elixirgen Therapeutics LLC
  • Galectin Therapeutics Inc
  • GWOXI Stem Cell Applied Technology
  • International Stem Cell Corporation
  • Mallinckrodt Pharmaceuticals
  • Nimbus Therapeutics
  • Novartis AG
  • Pharmicell Co Ltd
  • Promethera Biosciences
  • Rohto Pharmaceutical Co Ltd
  • Synlogic
  • TGV-Laboratories
  • VESSL Therapeutics Ltd
  • Xfibra Inc
  • XTuit Pharmaceuticals

Key Topics Covered

1 Table of Contents

2 Liver Cirrhosis Pipeline Analysis

3 Liver Cirrhosis - Company-wise Pipeline Analysis

4 Liver Cirrhosis R&D Pipeline Snapshots

5 Recent Developments in Liver Cirrhosis Pipeline

For more information about this report visit https://www.researchandmarkets.com/research/qt3ntv/2018_liver?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Liver and Kidney Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Liver and Kidney Disorders Drugs